Dr Wayne Thomas Rensimer, MD in Avalon, NJ - Ophthalmology

Dr Wayne Thomas Rensimer, MD is a Ophthalmology physician based in Avalon, New Jersey. Dr Wayne Thomas Rensimer is licensed to practice in Pennsylvania (license number MD014330E) and his current practice location is 6210 Ocean Dr, Avalon, New Jersey. He can be reached at his office (for appointments etc.) via phone at (609) 368-0386.

NPI number for Dr Wayne Thomas Rensimer is 1134302888 and his current mailing address is 6210 Ocean Dr, Avalon, New Jersey. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1134302888.

Contact Information

	Dr Wayne Thomas Rensimer, MD
	6210 Ocean Dr, Avalon, NJ 08202-1245
	(609) 368-0386
	Not Available

Physician's Profile

Full Name	Dr Wayne Thomas Rensimer
Gender	Male
Speciality	Ophthalmology
Location	6210 Ocean Dr, Avalon, New Jersey
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1134302888
Provider Enumeration Date: 12/17/2007
Last Update Date: 12/22/2011

Medical Identifiers

Medical identifiers for Dr Wayne Thomas Rensimer such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1134302888	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207W00000X	Ophthalmology	MD014330E (Pennsylvania)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Wayne Thomas Rensimer is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Wayne Thomas Rensimer, MD 6210 Ocean Dr, Avalon, NJ 08202-1245 Ph: () -	Dr Wayne Thomas Rensimer, MD 6210 Ocean Dr, Avalon, NJ 08202-1245 Ph: (609) 368-0386

News Archive

Sword Diagnostics receives patent on improved sensitivity technology for detection of biological organisms

Sword Diagnostics, Inc. is pleased to announce that the United States Patent Office (USPTO) has issued patent number 7,599,057 titled "Method and Apparatus for Detection of Biological Organisms using Raman Scattering" to the company.

K2M receives FDA clearance to market CAYMAN Minimally Invasive plate system

K2M, Inc., the largest privately held spinal device company in the world focused on developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market CAYMAN Minimally Invasive, the latest addition to the company's CAYMAN product family of plate systems already featuring CAYMAN Anterior, CAYMAN Buttress and CAYMAN Lateral.

Left-handers more likely to suffer from psychotic disorders

Researchers have long studied the connections between hand dominance and different aspects of the human brain. A new study out today in SAGE Open finds that among those with mental illnesses, left-handers are more likely to suffer from psychotic disorders such as schizophrenia than mood disorders.

Computers join the battle against novel coronavirus

Scientists everywhere are banding together to fight the novel coronavirus, and they're already making progress.

RiVax intradermal administration protects from mucosal, systemic ricin intoxication

Soligenix, Inc., a late-stage biopharmaceutical company, announced today the publication of an article in the June 2010 edition of Vaccine, which describes protection from mucosal and systemic ricin intoxication by intradermal administration of RiVax™, the Company's vaccine against ricin toxin.

Dr Wayne Thomas Rensimer, MD - Ophthalmology in Avalon, NJ